Year-end Sale % OFF 
Abstract
We conducted a postmarket analysis of treatment of the mid- and distal-popliteal artery (P2 and P3 segments) with the Bard LifeStent within the Society for Vascular Surgery Vascular Quality Initiative.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
